Home / Intelligence / Webinars / Omnichannel Orchestration After Patient Finding: Once You’ve Found The Patients, What Do You Do?
Available On Demand
Across life sciences commercialization organizations, attention is shifting to best practices in strengthening the connection between healthcare professionals (HCPs) and patients. Join Susheel Sukhtankar, Partner and Head of Commercial Analytics at Trinity Life Sciences, as he hosts a dynamic discussion on the nuances of omnichannel orchestration with panelists Jerry Luciano, Vice President of Omnichannel Marketing at TGaS Advisors, a Division of Trinity Life Sciences, and Anushank Anand, Director of Omnichannel Analytics in Trinity’s Commercial Analytics practice.
Key Webinar Topics
- Linking patients to HCPs
- Leveraging Next Best Action (NBA) tools to reach these HCPs
- Driving orchestration with analytical and domain expertise
Featuring
Susheel Sukhtankar
Partner &
Head of Commercial Analytics
Jerry Luciano
Vice President,
Omnichannel Marketing
Anushank Anand
Director,
Marketing Analytics
Complete the form below to view the on-demand webinar.
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.
*Gartner, Hype Cycle for Life Sciences Commercial Operations, Animesh Gandhi, published 13 August 2024.
GARTNER is a registered trademark and service mark of Gartner and Hype Cycle is a registered trademark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
Related Intelligence
Blog
The Evolution of CRM in Life Sciences: Navigating the Split
The split between Veeva and Salesforce marks a significant shift in the CRM landscape. Veeva is removing its CRM from the Salesforce cloud in September 2025 to focus on its “Veeva Vault” cloud solution for CRM. Veeva has communicated that it will maintain the current CRM product until September 2030 but will not be making any updates—and that it will absorb the cost of migration to the new Vault platform for all customers, excluding any customizations and integrations.
Read More
Blog
Medical Affairs Customer Engagement: What’s Next?
Medical Affairs teams are increasingly harnessing the power of omnichannel communication and orchestrated customer engagement to enhance interactions with key stakeholders. Changing customer preferences and access to content are key factors Medical Affairs teams are addressing by adopting more customer engagement channels. As these capabilities continue to expand, it is important for teams to embrace […]
Read More
Blog
Culture and Collaboration: Keys to Customer Engagement Success
We’re delighted to bring an external expert perspective to the “One Chapter Ahead” blog series and the important topic of culture and collaboration. Amy Saunders is a recognized customer experience global leader across life science verticals including pharma, med devices and consumer packaged goods (CPG) for companies such as J&J Consumer, W.L. Gore and Novartis. […]
Read More